Aldehyde dehydrogenase (E.C. 1.2.1.x) can catalyze detoxification of acetaldehydes. A novel acetaldehyde dehydrogenase (istALDH) from the non-Saccharomyces yeast Issatchenkia terricola strain XJ-2 has been previously characterized. In this work, Lactococcus lactis with the NIsin Controlled Expression (NICE) System was applied to express the aldehyde dehydrogenase gene (istALDH) in order to catalyze oxidation of acetaldehyde at low pH. A recombinant L. lactis NZ3900 was obtained and applied for the detoxification of acetaldehyde as whole-cell biocatalysts. The activity of IstALDH in L. lactis NZ3900 (pNZ8148-istALDH) reached 36.4 U mL when the recombinant cells were induced with 50 ng mL nisin at 20 °C for 2 h. The IstALDH activity of recombinant L. lactis cells showed higher stability at 37 °C and pH 4.0 compared with the crude enzyme. L. lactis NZ3900 (pNZ8148-istALDH) could convert acetaldehyde at pH 2.0 while the crude enzyme could not. Moreover, the resting cells of L. lactis NZ3900 (pNZ8148-istALDH) showed a 2.5-fold higher activity and better stability in catalyzing oxidation of acetaldehyde at pH 2.0 compared with that of Escherichia coli expressing the IstALDH. Taken together, the L. lactis cells expressing recombinant IstALDH are potential whole-cell biocatalysts that can be applied in the detoxification of aldehydes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s12010-017-2573-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Immunogenicity and protective efficacy of a recombinant lactococcus lactis vaccine against HSV-1 infection.
Microb Cell Fact
September 2024
Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, 453003, China.
Article Synopsis
- Herpes simplex virus type 1 (HSV-1) is linked to serious health issues including viral encephalitis and neonatal infections, prompting the exploration of vaccines for prevention.
- Researchers created a genetically modified strain of Lactococcus lactis (NZ3900-gD-IL-2-Fc) to express a protective viral antigen, aiming to enhance immune responses.
- Their findings showed that this recombinant vaccine significantly increased the production of antibodies and immune cell activity in mice, suggesting its potential effectiveness against HSV-1 infection.
Oral administration of recombinant Lactococcus lactis expressing largemouth bass (Micropterus salmoides) IFNa3 protein enhances immune response against largemouth bass virus (LMBV) infection.
Fish Shellfish Immunol
November 2024
National Key Laboratory of Agricultural Microbiology, College of Fisheries, Huazhong Agricultural University, Wuhan, 430070, Hubei, China; Hubei Engineering Technology Research Center for Aquatic Animal Diseases Control and Prevention, Wuhan, 430070, Hubei, China. Electronic address:
Article Synopsis
- Largemouth bass virus (LMBV) poses a serious threat to largemouth bass, leading to high mortality rates and economic losses.
- This study investigates the use of genetically modified Lactococcus lactis to deliver interferon a3 (IFNa3) orally to enhance the immune response in largemouth bass against LMBV.
- Results showed that fish receiving the recombinant L. lactis achieved a 70% survival rate post-LMBV challenge, significantly higher than control groups, with improved immune responses and lower viral loads.
Stability and expression of K-ras mimotopes in freeze-dried recombinant Lactococcus lactis NZ3900-fermented milk powder during storage in vacuum packaging.
J Appl Microbiol
July 2024
Department of Food Science and Nutrition, Faculty of Applied Sciences, UCSI University, 56000 Cheras, Wilayah Persekutuan Kuala Lumpur, Malaysia.
Aims: This study aims to evaluate the storage stability of the freeze-dried recombinant Lactococcus lactis NZ3900-fermented milk powder expressing K-ras (Kristen rat sarcoma viral oncogene homolog) mimotopes targeting colorectal cancer in vacuum packaging.
Methods And Results: The freeze-dried L. lactis-fermented milk powder stored in 4-ply retortable polypropylene (RCPP)-polyamide (PA)-aluminium (AL)-polyethylene terephthalate (PET) and aluminium polyethylene (ALPE) was evaluated throughout 49 days of accelerated storage (38°C and 90% relative humidity).
Application of Recombinant Lactic Acid Bacteria (LAB) Live Vector Oral Vaccine in the Prevention of F4+ Enterotoxigenic .
Vaccines (Basel)
March 2024
National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China.
Enterotoxigenic (ETEC) causes severe diarrhea in piglets. The current primary approach for ETEC prevention and control relies on antibiotics, as few effective vaccines are available. Consequently, an urgent clinical demand exists for developing an effective vaccine to combat this disease.
View Article and Find Full Text PDFPrevention and control of chicken coccidiosis construction of recombinant Lactococcus lactis expressing chicken IL-4 and IL-2 fusion protein and its immune synergistic effect on chicken coccidia live vaccine.
Poult Sci
April 2023
College of Veterinary Medicine, Shanxi Agricultural University, Taigu, Jinzhong, 030801, China.
Intestinal mucosa injury and loss of weight gain are unavoidable while using live vaccine strain to prevent chicken coccidiosis. In this study, recombinant Lactococcus lactis NZ3900/pNZ8149-IL-4-IL-2, expressing the fusion protein of chicken IL-4 and IL-2, was constructed using food-grade NICE expression system, trying to develop a possible oral immune adjuvant to enhance the immune effect of the live vaccine against chicken coccidiosis and minimize its adverse effects. Chickens were given different doses of recombinant L.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!